コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 rium avium complex (MAC) and 69 (36%) for M. abscessus.
2 bserved in M. marinum and the smallest in M. abscessus.
3 of a series of indolecarboxamides against M. abscessus.
4 ycobacteria including M. tuberculosis and M. abscessus.
5 topic shifts from incorporation of 15N in M. abscessus.
6 enum varied from those of M. chelonae and M. abscessus.
7 solates of M. chelonae and 25 isolates of M. abscessus.
8 t distinguish Mycobacterium chelonae from M. abscessus.
9 ne sequencing to identify M. chelonae and M. abscessus.
10 tiate M. immunogenum from M. chelonae and M. abscessus.
11 ting that this clone is a subgroup within M. abscessus.
12 erial species Mycobacterium fortuitum and M. abscessus.
13 The isolates were later identified as M. abscessus.
14 ers Mycobacterium smegmatis or Mycobacterium abscessus.
15 occur during chronic lung infection with M. abscessus.
16 20% of U.S. isolates of M. abscessus subsp. abscessus.
17 erm(41) genotype is a useful adjunct for M. abscessus.
18 table to test antibiotic activity against M. abscessus.
19 showed promising in vivo activity against M. abscessus.
20 which we propose the name "Para-streptomyces abscessus."
21 l isolates identified 2 clonal strains of M. abscessus; 1 clone was isolated from water sources at a
22 acterized clinical isolates comprising 29 M. abscessus, 15 M. massiliense, and 2 M. bolletii isolates
24 or rapidly growing mycobacteria (98% were M. abscessus), 78% (29 of 37) for M. kansasii, and 26% (9 o
26 iduals with cystic fibrosis (CF), in whom M. abscessus accelerates inflammatory lung damage, leading
27 alues for 81 isolates of M. abscessus subsp. abscessus and 12 isolates of M. abscessus subsp. massili
28 identified 41 Mycobacterium abscessus subsp. abscessus and 13 M. abscessus subsp. massiliense isolate
33 of two clonal groups for M. abscessus subsp. abscessus and five clonal groups for M. abscesssus subsp
34 reviously identified as being M. chelonae/M. abscessus and identified M. massiliense from isolates fr
35 g of M. fortuitum against clarithromycin; M. abscessus and M. chelonae against the aminoglycosides; a
38 enome, regions that discriminated between M. abscessus and M. massiliense were identified through arr
39 d three pairs of closely related strains: M. abscessus and M. massiliense, M. mucogenicum and M. phoc
42 olates were typed as M. abscessus subspecies abscessus and were clonally related within each patient.
43 oscopes and endoscopic cleaning machines (M. abscessus) and contaminated hospital water supplies (M.
44 tes of N. cyriacigeorgica, N. asteroides, N. abscessus, and N. otitidiscaviarum were susceptible to t
45 bmitted as M. chelonae were identified as M. abscessus, and one isolate submitted as M. abscessus was
46 cterium fortuitum group, three Mycobacterium abscessus, and three Mycobacterium chelonae isolates) we
47 rium fortuitum group, three of Mycobacterium abscessus, and three of Mycobacterium chelonae) were tes
48 bacterial infections caused by Mycobacterium abscessus are responsible for a range of disease manifes
49 metic mean = 1.5% of hsp65 sequences) and M. abscessus (arithmetic mean = 0.006% of hsp65 sequences).
52 We report the first series of Mycobacterium abscessus bacteremia after cytokine-induced killer cell
53 tibility breakpoints for M. abscessus subsp. abscessus be changed from </=2 to </=4 mug/ml and that i
54 ly effective at preventing infection with M. abscessus because it is a ubiquitous environmental sapro
57 s demonstrates that the inability to type M. abscessus by PFGE is associated with a single clone of o
58 of using thiourea-containing buffer with M. abscessus by studying 69 isolates not previously typeabl
59 resistance in Mycobacterium abscessus subsp. abscessus, calling into question the usefulness of macro
61 ses (57%; odds ratio = 0.7, P < 0.05) and M. abscessus cases (51%; odds ratio = 0.5, P < 0.01) than i
63 tidolipid in the outermost portion of the M. abscessus cell wall masks underlying cell wall lipids in
64 s provides an explanation whereby initial M. abscessus colonization of abnormal lung airways escapes
67 equencing (26 isolates of the M. chelonae-M. abscessus complex and 64 remaining isolates, including M
72 g susceptibility testing, all isolates of M. abscessus exhibited resistance to tobramycin (MIC of 8 t
75 s thought to be colonized with Mycobacterium abscessus for 13 yr prior to developing clinically appar
77 g were done on 168 consecutive isolates of M abscessus from 31 patients attending an adult cystic fib
80 cobacteria (RGM), particularly Mycobacterium abscessus, from individuals with cystic fibrosis (CF) is
81 is facilitated by biofilm formation, with M. abscessus glycopeptidolipids playing an important role.
83 e M. avium complex (MAC), the M. chelonae-M. abscessus group (MCAG), the M. fortuitum group (MFG), an
84 bscessus (M. abscessus sensu lato, or the M. abscessus group) comprises three closely related taxa wh
85 Mycobacterium massiliense (Mycobacterium abscessus group) is an emerging pathogen causing pulmona
86 e erm(41) and rrl genes in the Mycobacterium abscessus group, a multiplex real-time PCR assay for cla
88 ugh colony morphology shift in Mycobacterium abscessus has been implicated in loss of glycopeptidolip
91 ncluding M. immunogenum, M. chelonae, and M. abscessus, have been associated with nosocomial infectio
94 cording in the in vivo physiopathology of M. abscessus infection and emphasizes cording as a mechanis
95 from nine non-CF patients with persistent M. abscessus infection were characterized by colony morphol
96 3 drugs usually combined for treatment of M. abscessus infection, cefoxitin was the most active becau
98 al isolates, we show that the majority of M. abscessus infections are acquired through transmission,
100 d chemical structure class active against M. abscessus infections with promising translational develo
108 differentiation of these two species from M. abscessus is difficult and relies on the sequencing of o
113 ed whole-genome sequencing of 11 clinical M. abscessus isolates derived from eight U.S. patients with
114 -genome sequencing data demonstrated that M. abscessus isolates from 16 patients were unrelated, diff
116 Whole-genome sequencing was applied to 27 M. abscessus isolates from the 20 patients in this cohort t
117 liense and 15% to 20% of M. abscessus subsp. abscessus isolates renders these species intrinsically m
118 .S. and Western European M. abscessus subsp. abscessus isolates that are genetically distinct from ot
119 Previous population studies of clinical M. abscessus isolates utilized multilocus sequence typing o
120 d to the unambiguous identification of 26 M. abscessus isolates, 7 M. massiliense isolates, and 2 M.
125 cal to the CLSI guidelines for Mycobacterium abscessus: </=16 mug/ml for susceptible, 32 mug/ml for i
127 ough, wild-type human clinical isolate of M. abscessus (M. abscessus-R) and a smooth, attenuated muta
128 PCR for straightforward identification of M. abscessus, M. massiliense, and M. bolletii and the asses
129 ion and typing of 42 clinical isolates of M. abscessus, M. massiliense, and M. bolletii from patients
131 ates with ambiguous species identities as M. abscessus-M. massiliense by rpoB, hsp65, and secA sequen
132 verscores resistance and that isolates of M. abscessus/M. chelonae from CF patients are more likely t
134 also in few samples containing Mycobacterium abscessus,Mycobacterium gordonae, o rMycobacterium therm
135 acteria (41%), fungi (10%) and Mycobacterium abscessus, Mycoplasma hominis and Lactobacillus sp. (one
136 ubsp. bolletii (n = 24), M. abscessus subsp. abscessus (n = 6), Mycobacterium fortuitum (n = 3), Myco
137 re used to identify 75 isolates as either M. abscessus or M. chelonae that were originally submitted
138 who presented with multifocal Mycobacterium abscessus osteomyelitis (patient 1) and disseminated CMV
139 ulous mycobacteria, especially Mycobacterium abscessus, post-transplantation survival has not been de
141 erved that the increased virulence of the M. abscessus R variant compared with the S variant correlat
142 ast-mycobacterium microcolony assay, with M. abscessus-R exhibiting growth characteristics similar to
143 phagocyte aggregates develop at sites of M. abscessus-R infection, but are absent with M. abscessus-
147 e human clinical isolate of M. abscessus (M. abscessus-R) and a smooth, attenuated mutant (M. abscess
150 reported for virulent M. tuberculosis and M. abscessus-S exhibiting growth characteristics similar to
154 clude that a mutation has occurred in the M. abscessus-S variant which has altered the ability of thi
155 essus-R) and a smooth, attenuated mutant (M. abscessus-S) which spontaneously dissociated from the cl
158 onomic statuses are under revision, i.e., M. abscessus sensu stricto, Mycobacterium bolletii, and Myc
159 cobacterium immunogenum, M. chelonae, and M. abscessus, showed various susceptibilities to the glutar
160 udy we demonstrate that rough variants of M. abscessus stimulate the human macrophage innate immune r
162 ern) occurs with almost 50% of Mycobacterium abscessus strains during pulsed-field gel electrophoresi
163 xplores the genomic diversity of clinical M. abscessus strains from multiple continents and provides
164 om 3 confirmed infections grew Mycobacterium abscessus strains that were indistinguishable by pulsed-
165 PCR can be used for genetic comparison of M. abscessus strains, including strains which cannot be com
166 of a patient with disseminated Mycobacterium abscessus, Streptococcus viridians bacteremia, and cytom
167 erium abscessus subsp. bolletii (n = 24), M. abscessus subsp. abscessus (n = 6), Mycobacterium fortui
168 tedizolid MIC90 values for 81 isolates of M. abscessus subsp. abscessus and 12 isolates of M. abscess
169 bases accurately identified 41 Mycobacterium abscessus subsp. abscessus and 13 M. abscessus subsp. ma
170 ted the presence of two clonal groups for M. abscessus subsp. abscessus and five clonal groups for M.
171 ithromycin susceptibility breakpoints for M. abscessus subsp. abscessus be changed from </=2 to </=4
173 ssus subsp. massiliense and 15% to 20% of M. abscessus subsp. abscessus isolates renders these specie
174 closely related U.S. and Western European M. abscessus subsp. abscessus isolates that are genetically
176 ucible macrolide resistance in Mycobacterium abscessus subsp. abscessus, calling into question the us
178 The species identified were Mycobacterium abscessus subsp. bolletii (n = 24), M. abscessus subsp.
179 eregrinum and a nonfunctional erm gene in M. abscessus subsp. massiliense and 15% to 20% of M. absces
180 cterium abscessus subsp. abscessus and 13 M. abscessus subsp. massiliense isolates identified by whol
181 essus subsp. abscessus and 12 isolates of M. abscessus subsp. massiliense were 8 mug/ml and 4 mug/ml,
183 utbreaks of near-identical isolates of the M abscessus subspecies massiliense (from 11 patients), dif
185 ients with genetically related strains of M. abscessus that had been previously typed by variable-num
187 smear patterns were identical to those of M. abscessus type strain ATCC 19977, which had a nonsmear p
189 t respiratory epithelial cells respond to M. abscessus variants lacking GPL with expression of IL-8 a
195 ncident NTM infections from either MAC or M. abscessus were less likely to have had chronic azithromy
197 Several bacterial species, including M. abscessus, were cultured from an opened multidose supple
199 uberculous mycobacterium (NTM) Mycobacterium abscessus, which causes progressive lung damage and is e
200 ncing of the erm gene of M. abscessus subsp. abscessus will predict inducible macrolide susceptibilit
201 ve not demonstrated cross-transmission of M. abscessus within our hospital, except between 1 sibling
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。